Synergistic Sono-Gene Therapy of Gastric Cancer via Nanoparticle-Based Delivery of Chlorin e6 and siRNA

View at publisher Summarise with VIRAT
Authors: Tingting Xiang, Ying Xia, Hong Du, Yong Jin, Dicheng Yang, Depeng Liu, Sixi Wei, Cunfeng Song, Hai Huang
Cited by: 0
References: 44

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Gastric cancer remains one of the most pressing global health challenges, with its high mortality rate primarily attributed to aggressive tumor invasiveness and strong metastatic potential. This grim scenario underscores the urgent need for effective, feasible, and innovative therapeutic strategies. In this study, we developed a targeted nanoparticle system (iBCsi) that codelivers the sonosensitizer chlorin e6 (Ce6) and small interfering RNA (siRNA) for sono-gene therapy. It has a size of 100.21 ± 1.22 nm. This system enables the implementation of a “suppress EMT-promote apoptosis” strategy: Specifically, the siRNA reduces tumor invasiveness via downregulating LINC00963, an overexpressed long noncoding RNA (LncRNA) known to drive epithelial–mesenchymal transition (EMT). Concurrently, upon ultrasound irradiation, iBCsi generates high levels of reactive oxygen species (ROS), thereby inducing tumor cell apoptosis. This synergistic therapeutic approach successfully suppresses tumor growth and EMT via the combination of gene silencing and sonodynamic therapy, not only deepening the mechanistic understanding of gastric cancer therapy but also enhancing its translational potential within precision oncology.

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Photodynamic Therapy Research Studies RNA Interference and Gene Delivery

Publication details

Journal / source
ACS Applied Nano Materials
Volume
9
Issue
14
Pages
6056–6069
Publication date
31 March 2026
Language
EN